Paid articlePaywallDon’t restrict Chinese biotech:
Patients benefit from faster, cheaper treatments, wherever they are invented
economist.com/leaders/2026/06/18/dont-restrict-chinese-biotech
Story Details
| Last Updated | |
| Total Articles | 9 |
Main Topics
unilateral transfer of free benefits from the public sector to private individuals
More articles on this subject
Previous
Paid articlePaywall Don’t restrict Chinese biotech: Patients benefit from faster, cheaper treatments, wherever they are invented
economist.com/leaders/2026/06/18/dont-restrict-chinese-biotech
Next
Similar to This
Previous
STAT Nov 05
Paid articlePaywall In China, a flood of controversial clinical trials slows to a trickle: Following patient deaths, China restricts investigator-initiated biotech trials ...
statnews.com/2026/11/05/china-biotech-restrictions-impact-rare-disease-investigator-initiated-trial/
Barron's Nov 03
Paid articlePaywall How to Invest in the Rise of China’s Biotech: Buy U.S. Drug Stocks: Many of the hot new drug candidates in the U.S. were developed Chinese companies.
barrons.com/articles/china-biotech-us-drug-stocks-8aa0a428
Paid articlePaywall The quest for immortality has become serious business: As entrepreneurs peddle scans and supplements, biotechs are probing the mysteries of ageing
economist.com/business/2026/11/02/the-quest-for-immortality-has-become-serious-business
Barron's Oct 23
Paid articlePaywall U.S. Treasury Wants to Rein In Deals for Chinese Biotech and AI: The prohibitions could cut off Big Pharma from Chinese biotechs—the source of many promising ...
barrons.com/articles/treasury-ai-biotech-chips-china-investment-12c4e533
STAT Oct 22
Paid articlePaywall Will the Treasury restrict U.S. investment in the Chinese biotech sector?: Today's biotech includes Moderna and Merck's ESMO upcoming data ...
statnews.com/2026/10/22/biotech-news-treasury-restrictions-for-us-investment-in-chinese-biotech/
China proposes biotech export controls that exempt licensing deals
dlvr.it/TVxXQX
OpinionChina biotech's ingenuity extends to dealmaking: Chinese drugmakers' 2026 overseas licensing deals just hit $139 bln, beating last year's record ...
reuters.com/commentary/breakingviews/china-biotechs-ingenuity-extends-dealmaking-2026-10-16/
STAT Oct 09
Paid articlePaywall Roche goes beyond licensing in deal with Chinese biotech: Today's biotech news includes: DOJ signals it will start scrutinizing drugmakers ...
statnews.com/2026/10/08/biotech-news-roche-goes-beyond-licensing-in-deal-with-chinese-biotech/
STAT Sep 30
Paid articlePaywall Three biotech updates, including accusations of theft and and a new lobbying leader
statnews.com/2026/09/30/biotech-news-updates-accusations-of-theft-new-phrma-guy/
Paid articlePaywall Biotech is one area where the US can afford to let China flourish: Drugmakers are picking through the Chinese biotech sector to find treatments and technologies ...
ft.com/content/0c7eac88-bc13-42be-aa18-f78ec1483ca6
Sandoz expands biosimilars business with Chinese biotech deal: Sandoz has signed a multi-million-dollar agreement with Chinese biotech company Shanghai Henlius ...
swissinfo.ch/eng/pharma-supply-chains/sandoz-expands-biosimilars-business-with-chinese-biotech-deal/91907903
Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first : Global biotech firms are increasingly being drawn to Hong Kong for its growing ...
cnbc.com/2026/07/22/axiom-aiosciences-ipo-listing-hong-kong.html
China’s biotech surge sparks US security concerns as drug trials break records in 2025
thestar.com.my/aseanplus/aseanplus-news/2026/06/27/chinas-biotech-surge-sparks-us-security-concerns-as-drug-trials-break-records-in-2025
Paid articlePaywall China ‘outpacing the US’ in biotech race to find cure for Parkinson’s disease: A leading Chinese neurologist says publicly available data shows a clear lead in ...
scmp.com/news/china/science/article/3353950/china-outpacing-us-biotech-race-find-cure-parkinsons-disease
STAT Mar 31
Paid articlePaywall Biotech VCs move upstream in China’s scientific pipelines as competition grows fiercer
statnews.com/2026/03/31/venture-capital-moves-upstream-chase-china-biotech-deals-pre-publication/
Paid articlePaywall In rude health: the rise of Chinese pharma: Our weekly podcast on China. This week, can Chinese biotechs go global?
economist.com/podcasts/2025/10/07/in-rude-health-the-rise-of-chinese-pharma
Chinese biotech shares surge as Big Pharma looks to license cancer treatments: Sector returns are over 60% this year, with investors impressed by rapid pace of ...
ft.com/content/1beb84a6-71c1-494f-8a6c-b10a5da8b01b
China's biotech boom leaves U.S. playing catch-up: China has passed the U.S. in clinical trials, marking a turning point in the race to dominate life sciences.
axios.com/2025/05/29/china-biotech-boom-us-drug-trials
Chinese biotechs eye Swiss collaboration as relations with US sour: With growing uncertainty in the US, Chinese companies are swooping in to present themselves ...
swissinfo.ch/eng/healthcare-innovation/chinese-biotechs-eye-swiss-collaboration-as-relations-with-us-sour/89285587
Next